Global and China Hydroxyprogesterone Caproate Injection Market Insights, Forecast to 2027

Publisher Name :
Date: 03-Sep-2021
No. of pages: 131
Inquire Before Buying

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.

Market Analysis and Insights: Global and China Hydroxyprogesterone Caproate Injection Market

This report focuses on global and China Hydroxyprogesterone Caproate Injection market.

In 2020, the global Hydroxyprogesterone Caproate Injection market size was US$ 259 million and it is expected to reach US$ 287.6 million by the end of 2027, with a CAGR of 1.5% during 2021-2027. In China the Hydroxyprogesterone Caproate Injection market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Hydroxyprogesterone Caproate Injection Scope and Market Size

Hydroxyprogesterone Caproate Injection market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hydroxyprogesterone Caproate Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Hydroxyprogesterone Caproate Injection market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- 1 mL Injection(Including 1.1 mL)

- 5 mL Injection

Segment by Application

- Hospitals Injection

- Clinics Injection

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- AMAG Pharmaceuticals

- Mcguff Pharmaceuticals Inc

- Aspen Oss B.V

- American Regent, Inc.

- Mylan Institutional

Global and China Hydroxyprogesterone Caproate Injection Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Hydroxyprogesterone Caproate Injection Product Introduction
1.2 Market by Type
1.2.1 Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Type
1.2.2 1 mL Injection(Including 1.1 mL)
1.2.3 5 mL Injection
1.3 Market by Application
1.3.1 Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Application
1.3.2 Hospitals Injection
1.3.3 Clinics Injection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hydroxyprogesterone Caproate Injection Market Size, Estimates and Forecasts
2.1.1 Global Hydroxyprogesterone Caproate Injection Revenue 2016-2027
2.1.2 Global Hydroxyprogesterone Caproate Injection Sales 2016-2027
2.2 Global Hydroxyprogesterone Caproate Injection, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hydroxyprogesterone Caproate Injection Historical Market Size by Region (2016-2021)
2.3.1 Global Hydroxyprogesterone Caproate Injection Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hydroxyprogesterone Caproate Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hydroxyprogesterone Caproate Injection Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Region (2022-2027)
2.4.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Region (2022-2027)
3 Global Hydroxyprogesterone Caproate Injection Competitor Landscape by Players
3.1 Global Top Hydroxyprogesterone Caproate Injection Manufacturers by Sales
3.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Manufacturer (2016-2021)
3.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hydroxyprogesterone Caproate Injection Manufacturers by Revenue
3.2.1 Key Hydroxyprogesterone Caproate Injection Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Manufacturers (2016-2021)
3.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hydroxyprogesterone Caproate Injection Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hydroxyprogesterone Caproate Injection Revenue in 2020
3.2.6 Global Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hydroxyprogesterone Caproate Injection Price by Manufacturers
3.4 Global Hydroxyprogesterone Caproate Injection Manufacturing Base Distribution, Product Types
3.4.1 Hydroxyprogesterone Caproate Injection Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hydroxyprogesterone Caproate Injection Product Type
3.4.3 Date of International Manufacturers Enter into Hydroxyprogesterone Caproate Injection Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Hydroxyprogesterone Caproate Injection Market Size by Type (2016-2021)
4.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2016-2021)
4.1.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2016-2021)
4.1.3 Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hydroxyprogesterone Caproate Injection Market Size Forecast by Type (2022-2027)
4.2.1 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Type (2022-2027)
4.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Type (2022-2027)
4.2.3 Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Hydroxyprogesterone Caproate Injection Market Size by Application (2016-2021)
5.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2016-2021)
5.1.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2016-2021)
5.1.3 Hydroxyprogesterone Caproate Injection Price by Application (2016-2021)
5.2 Hydroxyprogesterone Caproate Injection Market Size Forecast by Application (2022-2027)
5.2.1 Global Hydroxyprogesterone Caproate Injection Sales Forecast by Application (2022-2027)
5.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Application (2022-2027)
5.2.3 Global Hydroxyprogesterone Caproate Injection Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2016-2027
6.1.1 China Hydroxyprogesterone Caproate Injection Sales YoY Growth 2016-2027
6.1.2 China Hydroxyprogesterone Caproate Injection Revenue YoY Growth 2016-2027
6.1.3 China Hydroxyprogesterone Caproate Injection Market Share in Global Market 2016-2027
6.2 China Hydroxyprogesterone Caproate Injection Market Size by Players (International and Local Players)
6.2.1 China Top Hydroxyprogesterone Caproate Injection Players by Sales (2016-2021)
6.2.2 China Top Hydroxyprogesterone Caproate Injection Players by Revenue (2016-2021)
6.3 China Hydroxyprogesterone Caproate Injection Historic Market Review by Type (2016-2021)
6.3.1 China Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2016-2021)
6.3.2 China Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2016-2021)
6.3.3 China Hydroxyprogesterone Caproate Injection Price by Type (2016-2021)
6.4 China Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Hydroxyprogesterone Caproate Injection Sales Forecast by Type (2022-2027)
6.4.2 China Hydroxyprogesterone Caproate Injection Revenue Forecast by Type (2022-2027)
6.4.3 China Hydroxyprogesterone Caproate Injection Price Forecast by Type (2022-2027)
6.5 China Hydroxyprogesterone Caproate Injection Historic Market Review by Application (2016-2021)
6.5.1 China Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2016-2021)
6.5.2 China Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2016-2021)
6.5.3 China Hydroxyprogesterone Caproate Injection Price by Application (2016-2021)
6.6 China Hydroxyprogesterone Caproate Injection Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Hydroxyprogesterone Caproate Injection Sales Forecast by Application (2022-2027)
6.6.2 China Hydroxyprogesterone Caproate Injection Revenue Forecast by Application (2022-2027)
6.6.3 China Hydroxyprogesterone Caproate Injection Price Forecast by Application (2022-2027)
7 North America
7.1 North America Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2016-2027
7.2 North America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
7.2.1 North America Hydroxyprogesterone Caproate Injection Sales by Country (2016-2021)
7.2.2 North America Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hydroxyprogesterone Caproate Injection Market Facts & Figures by Region
8.2.1 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2016-2021)
8.2.2 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2016-2027
9.2 Europe Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
9.2.1 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2016-2021)
9.2.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2016-2027
10.2 Latin America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
10.2.1 Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2016-2021)
10.2.2 Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
11.2.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 AMAG Pharmaceuticals
12.1.1 AMAG Pharmaceuticals Corporation Information
12.1.2 AMAG Pharmaceuticals Description and Business Overview
12.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Products Offered
12.1.5 AMAG Pharmaceuticals Recent Development
12.2 Mcguff Pharmaceuticals Inc
12.2.1 Mcguff Pharmaceuticals Inc Corporation Information
12.2.2 Mcguff Pharmaceuticals Inc Description and Business Overview
12.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Products Offered
12.2.5 Mcguff Pharmaceuticals Inc Recent Development
12.3 Aspen Oss B.V
12.3.1 Aspen Oss B.V Corporation Information
12.3.2 Aspen Oss B.V Description and Business Overview
12.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Products Offered
12.3.5 Aspen Oss B.V Recent Development
12.4 American Regent, Inc.
12.4.1 American Regent, Inc. Corporation Information
12.4.2 American Regent, Inc. Description and Business Overview
12.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2016-2021)
12.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Products Offered
12.4.5 American Regent, Inc. Recent Development
12.5 Mylan Institutional
12.5.1 Mylan Institutional Corporation Information
12.5.2 Mylan Institutional Description and Business Overview
12.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Products Offered
12.5.5 Mylan Institutional Recent Development
12.11 AMAG Pharmaceuticals
12.11.1 AMAG Pharmaceuticals Corporation Information
12.11.2 AMAG Pharmaceuticals Description and Business Overview
12.11.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Products Offered
12.11.5 AMAG Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hydroxyprogesterone Caproate Injection Industry Trends
13.2 Hydroxyprogesterone Caproate Injection Market Drivers
13.3 Hydroxyprogesterone Caproate Injection Market Challenges
13.4 Hydroxyprogesterone Caproate Injection Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hydroxyprogesterone Caproate Injection Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 1 mL Injection(Including 1.1 mL)
Table 3. Major Manufacturers of 5 mL Injection
Table 4. Global Hydroxyprogesterone Caproate Injection Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Hydroxyprogesterone Caproate Injection Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Hydroxyprogesterone Caproate Injection Sales by Regions (2016-2021) & (K Units)
Table 7. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Regions (2016-2021)
Table 8. Global Hydroxyprogesterone Caproate Injection Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Hydroxyprogesterone Caproate Injection Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Hydroxyprogesterone Caproate Injection Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Hydroxyprogesterone Caproate Injection Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Hydroxyprogesterone Caproate Injection Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Hydroxyprogesterone Caproate Injection Manufacturers by Revenue (US$ Million) in 2020
Table 16. Hydroxyprogesterone Caproate Injection Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Hydroxyprogesterone Caproate Injection Revenue Share by Manufacturers (2016-2021)
Table 18. Global Hydroxyprogesterone Caproate Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Hydroxyprogesterone Caproate Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxyprogesterone Caproate Injection as of 2020)
Table 20. Key Manufacturers Hydroxyprogesterone Caproate Injection Price (2016-2021) (US$/Unit)
Table 21. Hydroxyprogesterone Caproate Injection Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hydroxyprogesterone Caproate Injection Product Type
Table 23. Date of International Manufacturers Enter into Hydroxyprogesterone Caproate Injection Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Hydroxyprogesterone Caproate Injection Sales by Type (2016-2021) (K Units)
Table 26. Global Hydroxyprogesterone Caproate Injection Sales Share by Type (2016-2021)
Table 27. Global Hydroxyprogesterone Caproate Injection Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Hydroxyprogesterone Caproate Injection Revenue Share by Type (2016-2021)
Table 29. Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Hydroxyprogesterone Caproate Injection Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Hydroxyprogesterone Caproate Injection Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Hydroxyprogesterone Caproate Injection Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Hydroxyprogesterone Caproate Injection Sales by Application (2016-2021) (K Units)
Table 36. Global Hydroxyprogesterone Caproate Injection Sales Share by Application (2016-2021)
Table 37. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Hydroxyprogesterone Caproate Injection Revenue Share by Application (2016-2021)
Table 39. Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Hydroxyprogesterone Caproate Injection Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Hydroxyprogesterone Caproate Injection Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Hydroxyprogesterone Caproate Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Hydroxyprogesterone Caproate Injection Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Hydroxyprogesterone Caproate Injection Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. China Hydroxyprogesterone Caproate Injection Sales (K Units) of Key Companies (2016-2021)
Table 46. China Hydroxyprogesterone Caproate Injection Sales Share by Company (2016-2021)
Table 47. China Hydroxyprogesterone Caproate Injection Revenue (US$ Million) by Company (2016-2021)
Table 48. China Hydroxyprogesterone Caproate Injection Revenue Share by Company (2016-2021)
Table 49. China Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2016-2021)
Table 50. China Hydroxyprogesterone Caproate Injection Sales Share by Type (2016-2021)
Table 51. China Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2016-2021)
Table 53. China Hydroxyprogesterone Caproate Injection Sales (K Units) by Type (2022-2027)
Table 54. China Hydroxyprogesterone Caproate Injection Sales Share by Type (2022-2027)
Table 55. China Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Hydroxyprogesterone Caproate Injection Revenue Share by Type (2022-2027)
Table 57. China Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Type (2022-2027)
Table 58. China Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2016-2021)
Table 59. China Hydroxyprogesterone Caproate Injection Sales Share by Application (2016-2021)
Table 60. China Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2016-2021)
Table 62. China Hydroxyprogesterone Caproate Injection Sales (K Units) by Application (2022-2027)
Table 63. China Hydroxyprogesterone Caproate Injection Sales Share by Application (2022-2027)
Table 64. China Hydroxyprogesterone Caproate Injection Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Hydroxyprogesterone Caproate Injection Revenue Share by Application (2022-2027)
Table 66. China Hydroxyprogesterone Caproate Injection Price (US$/Unit) by Application (2022-2027)
Table 67. North America Hydroxyprogesterone Caproate Injection Sales by Country (2016-2021) & (K Units)
Table 68. North America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2016-2021)
Table 69. North America Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2016-2021)
Table 75. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2016-2021) & (K Units)
Table 76. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2016-2021)
Table 77. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2016-2021)
Table 79. Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2016-2021)
Table 87. AMAG Pharmaceuticals Corporation Information
Table 88. AMAG Pharmaceuticals Description and Business Overview
Table 89. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product
Table 91. AMAG Pharmaceuticals Recent Development
Table 92. Mcguff Pharmaceuticals Inc Corporation Information
Table 93. Mcguff Pharmaceuticals Inc Description and Business Overview
Table 94. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. Mcguff Pharmaceuticals Inc Product
Table 96. Mcguff Pharmaceuticals Inc Recent Development
Table 97. Aspen Oss B.V Corporation Information
Table 98. Aspen Oss B.V Description and Business Overview
Table 99. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. Aspen Oss B.V Product
Table 101. Aspen Oss B.V Recent Development
Table 102. American Regent, Inc. Corporation Information
Table 103. American Regent, Inc. Description and Business Overview
Table 104. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. American Regent, Inc. Product
Table 106. American Regent, Inc. Recent Development
Table 107. Mylan Institutional Corporation Information
Table 108. Mylan Institutional Description and Business Overview
Table 109. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Mylan Institutional Product
Table 111. Mylan Institutional Recent Development
Table 112. Hydroxyprogesterone Caproate Injection Market Trends
Table 113. Hydroxyprogesterone Caproate Injection Market Drivers
Table 114. Hydroxyprogesterone Caproate Injection Market Challenges
Table 115. Hydroxyprogesterone Caproate Injection Market Restraints
Table 116. Hydroxyprogesterone Caproate Injection Customers List
Table 117. Hydroxyprogesterone Caproate Injection Distributors List
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Hydroxyprogesterone Caproate Injection Product Picture
Figure 2. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2020 & 2027
Figure 3. 1 mL Injection(Including 1.1 mL) Product Picture
Figure 4. 5 mL Injection Product Picture
Figure 5. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application in 2020 & 2027
Figure 6. Hospitals Injection
Figure 7. Clinics Injection
Figure 8. Hydroxyprogesterone Caproate Injection Report Years Considered
Figure 9. Global Hydroxyprogesterone Caproate Injection Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hydroxyprogesterone Caproate Injection Market Size 2016-2027 (US$ Million)
Figure 11. Global Hydroxyprogesterone Caproate Injection Sales 2016-2027 (K Units)
Figure 12. Global Hydroxyprogesterone Caproate Injection Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2016-2021)
Figure 14. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region in 2020
Figure 15. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2016-2021)
Figure 16. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Region in 2020
Figure 17. Global Hydroxyprogesterone Caproate Injection Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Hydroxyprogesterone Caproate Injection Revenue in 2020
Figure 19. Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2016-2021)
Figure 21. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type in 2020
Figure 22. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2016-2021)
Figure 23. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type in 2020
Figure 24. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2016-2021)
Figure 25. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application in 2020
Figure 26. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2016-2021)
Figure 27. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application in 2020
Figure 28. China Hydroxyprogesterone Caproate Injection Sales Growth Rate 2016-2027 (K Units)
Figure 29. China Hydroxyprogesterone Caproate Injection Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Hydroxyprogesterone Caproate Injection Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Hydroxyprogesterone Caproate Injection Players Market Share by Revenue in Hydroxyprogesterone Caproate Injection in 2020
Figure 32. China Hydroxyprogesterone Caproate Injection Revenue Share by Type (2016-2021)
Figure 33. China Hydroxyprogesterone Caproate Injection Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Hydroxyprogesterone Caproate Injection Revenue Share by Application (2016-2021)
Figure 35. China Hydroxyprogesterone Caproate Injection Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Hydroxyprogesterone Caproate Injection Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Hydroxyprogesterone Caproate Injection Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Hydroxyprogesterone Caproate Injection Sales Market Share by Country in 2020
Figure 39. North America Hydroxyprogesterone Caproate Injection Revenue Market Share by Country in 2020
Figure 40. U.S. Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 41. U.S. Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Hydroxyprogesterone Caproate Injection Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Hydroxyprogesterone Caproate Injection Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country in 2020
Figure 47. Europe Hydroxyprogesterone Caproate Injection Revenue Market Share by Country in 2020
Figure 48. Germany Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Hydroxyprogesterone Caproate Injection Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Hydroxyprogesterone Caproate Injection Sales Market Share by Region in 2020
Figure 61. Asia Pacific Hydroxyprogesterone Caproate Injection Revenue Market Share by Region in 2020
Figure 62. China Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 73. Taiwan Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Hydroxyprogesterone Caproate Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Hydroxyprogesterone Caproate Injection Sales Growth Rate (2016-2021) (K Units)
Figure 7
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs